Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting (Q61402172)
Jump to navigation
Jump to search
scientific article published on 01 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting |
scientific article published on 01 March 2012 |
Statements
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial (English)
Stefania Gambetti
Laura Bristot
Monia Monti
Giovanni Parrinello
Roberto Ferrari
FABOLUS PRO Investigators